---
title: "CHEOY.US (CHEOY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CHEOY.US/news.md"
symbol: "CHEOY.US"
name: "CHEOY.US"
parent: "https://longbridge.com/en/quote/CHEOY.US.md"
datetime: "2026-03-13T21:21:00.069Z"
locales:
  - [en](https://longbridge.com/en/quote/CHEOY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CHEOY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CHEOY.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CHEOY.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CHEOY.US/news.md)


# CHEOY.US (CHEOY.US) — Related News

### [CochLear (OTCMKTS:CHEOY) Sees Unusually-High Trading Volume  - Time to Buy?](https://longbridge.com/en/news/278610102.md)
*2026-03-10T20:15:18.000Z*
> CochLear Ltd. (OTCMKTS:CHEOY) experienced a significant increase in trading volume, with 104,863 shares traded, up 237% 

### [Cochlear (ASX:COH) Holds Dividend as Profit Guidance Softens – What Is Management Signaling?](https://longbridge.com/en/news/276241428.md)
*2026-02-18T14:34:03.000Z*
> Cochlear Limited reported flat sales of A$1,167.2 million and a lower net income of A$161.5 million for half-year 2025, 

### [Cochlear  (CHEOF) Receives a Buy from Canaccord Genuity](https://longbridge.com/en/news/276092118.md)
*2026-02-17T03:15:17.000Z*
> Cochlear (CHEOF) has received a Buy rating from Canaccord Genuity, with a price target of A$330.00, while its shares clo

### [Ord Minnett Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/276031548.md)
*2026-02-16T04:35:17.000Z*
> In a report released today, from Ord Minnett maintained a Hold rating on Cochlear , with a price target of A$241.50.Pres

### [Morgans upgrades Cochlear  (CHEOF) to a Hold](https://longbridge.com/en/news/276016202.md)
*2026-02-15T23:05:56.000Z*
> Morgans has upgraded Cochlear (CHEOF) to a Hold rating with a price target of A$214.93, as reported by analyst Derek Jel

### [Morgan Stanley Sticks to Its Sell Rating for Cochlear  (CHEOF)](https://longbridge.com/en/news/273768133.md)
*2026-01-27T01:07:26.000Z*
> Morgan Stanley analyst David Bailey has maintained a Sell rating on Cochlear (CHEOF) with a price target of A$270.00. Th

### [Citi Sticks to Its Hold Rating for Cochlear  (CHEOF)](https://longbridge.com/en/news/273758099.md)
*2026-01-26T23:15:50.000Z*
> Citi analyst Laura Sutcliffe has maintained a Hold rating on Cochlear (CHEOF) with a price target of A$300.00. The analy

### [Health care roundup: Market talk](https://longbridge.com/en/news/272968532.md)
*2026-01-19T11:44:47.000Z*
> Find insight on Bayer, Cochlear, Australian healthcare stocks and more in the latest Market Talks covering Health Care.

### [Cochlear Ltd. Expands Access to Nucleus Nexa System for US Veterans](https://longbridge.com/en/news/271938350.md)
*2026-01-08T13:16:12.000Z*